Horizon Scanning aims to highlight important pharmaceutical and medical technology innovations before they reach the market by continuously gathering data and analyzing research and literature.
This improves insight in expected costs and enables timely decision making and (joint) price negotiations.
The Beneluxa Initiative on Pharmaceutical Policy aims to seek successful ways of collaborating on pharmaceutical policy. One of its goals is to set up a systematic approach on horizon scanning for pharmaceutical products through IHSI. The IHSI is open to any interested country. Countries interested in participating in the IHSI can contact info@beneluxa.org.
Open market consultation for Horizon Scanning
The open market consultation that took place end of 2018 aimed to inform companies and organisations that are active in this market regarding the upcoming public procurement procedure for the setting up of an international horizon scanning system (HSS) that will be initiated as a joint effort by the countries participating in the IHSI. The market consultation also aims to obtain market operators’ input on the viability of the procurement design and conditions, before launching the call for tender, provisionally planned in the first quarter of 2019.
The market consultation was open to all interested parties, regardless of their geographical location, size or governance structure of their organisation and was published on October 20th 2018 on the EU’s Official Journal (TED). On November 12th 2018 a meeting was held in the Hague for interested parties. The presentation from this meeting can be found below. The market consultation ended on the 27th of November 2018.
Results of open market consultation
The open market consultation has been concluded and the results can be found in the document below. The preparations for the tender launch are being made and interested parties will be informed as soon as more information can be made public on the tender procedure and timelines.
Last update: 05 March 2019